Company Filing History:
Years Active: 2019
Title: Mark Minie: Innovator in Therapeutic Strategies for Autoimmune Diseases
Introduction
Mark Minie is a prominent inventor based in Seattle, WA, known for his contributions to the field of therapeutic strategies for severe debilitating diseases. His innovative work focuses on addressing conditions associated with interferon signaling due to cGAS activation.
Latest Patents
Mark Minie holds a patent related to his invention titled "CGAS in systemic lupus erythematosus (SLE)." This patent provides therapeutic strategies for treating severe debilitating diseases linked to IFN-I due to cGAS activation. The invention includes compounds of Formula (I) and outlines pharmaceutical uses thereof. Additionally, it presents methods for treating autoimmune diseases or monogenic disorders by administering an effective amount of a compound of Formula (I). He has 1 patent to his name.
Career Highlights
Mark Minie is affiliated with the University of Washington, where he continues to advance research in the field of autoimmune diseases. His work has significant implications for developing new treatment options for patients suffering from these conditions.
Collaborations
Some of his notable coworkers include Keith B Elkon and Jie An, who contribute to the collaborative efforts in research and development within the university.
Conclusion
Mark Minie's innovative work in therapeutic strategies for autoimmune diseases highlights his commitment to advancing medical science. His contributions are paving the way for new treatment options that could significantly improve patient outcomes.